A randomized placebo-controlled trial of intermittent preventive treatment in pregnant women in the context of insecticide treated nets delivered through the antenatal clinic

dc.contributor.authorMenéndez, Clara
dc.contributor.authorBardají, Azucena
dc.contributor.authorSigaúque, Betuel
dc.contributor.authorRomagosa Pérez-Portabella, Cleofé
dc.contributor.authorSanz, Sergi
dc.contributor.authorSerra-Casas, Elisa
dc.contributor.authorMacete, Eusebio Víctor
dc.contributor.authorBerenguera, Anna
dc.contributor.authorDavid, Catarina
dc.contributor.authorDobaño, Carlota, 1969-
dc.contributor.authorNaniche, Denise
dc.contributor.authorMayor Aparicio, Alfredo Gabriel
dc.contributor.authorOrdi i Majà, Jaume
dc.contributor.authorMandomando, Inácio
dc.contributor.authorAponte, John J.
dc.contributor.authorMabunda, Samuel José Alvés
dc.contributor.authorAlonso, Pedro
dc.date.accessioned2016-03-01T10:44:19Z
dc.date.available2016-03-01T10:44:19Z
dc.date.issued2008-04-09
dc.date.updated2016-03-01T10:44:25Z
dc.description.abstractBackground:Current recommendations to prevent malaria in African pregnant women rely on insecticide treated nets(ITNs) and intermittent preventive treatment (IPTp). However, there is no information on the safety and efficacy of theircombined use.Methods:1030 pregnant Mozambican women of all gravidities received a long-lasting ITN during antenatal clinic (ANC)visits and, irrespective of HIV status, were enrolled in a randomised, double blind, placebo-controlled trial, to assess thesafety and efficacy of 2-dose sulphadoxine-pyrimethamine (SP). The main outcome was the reduction in low birth weight.Findings:Two-dose SP was safe and well tolerated, but was not associated with reductions in anaemia prevalence atdelivery (RR, 0.92 [95% CI, 0.79-1.08]), low birth weight (RR, 0.99 [95% CI, 0.70-1.39]), or overall placental infection(p = 0.964). However, the SP group showed a 40% reduction (95% CI, 7.40-61.20]; p = 0.020) in the incidence of clinicalmalaria during pregnancy, and reductions in the prevalence of peripheral parasitaemia (7.10% vs 15.15%) (p,0.001), and ofactively infected placentas (7.04% vs 13.60%) (p = 0.002). There was a reduction in severe anaemia at delivery of borderlinestatistical significance (p = 0.055). These effects were not modified by gravidity or HIV status. Reported ITN's use was morethan 90% in both groups.Conclusions:Two-dose SP was associated with a reduction in some indicators, but these were not translated to significantimprovement in other maternal or birth outcomes. The use of ITNs during pregnancy may reduce the need to administerIPTp. ITNs should be part of the ANC package in sub-Saharan Africa
dc.format.extent9 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec573164
dc.identifier.issn1932-6203
dc.identifier.pmid8398460
dc.identifier.pmid18398460
dc.identifier.urihttps://hdl.handle.net/2445/96004
dc.language.isoeng
dc.publisherPublic Library of Science (PLoS)
dc.relation.isformatofReproducció del document publicat a: http://dx.doi.org/10.1371/journal.pone.0001934
dc.relation.ispartofPLoS One, 2008, vol. 3, num. 4, p. e1934
dc.relation.urihttp://dx.doi.org/10.1371/journal.pone.0001934
dc.rightscc-by (c) Menéndez, et al., 2008
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es
dc.sourceArticles publicats en revistes (Medicina)
dc.subject.classificationEmbarassades
dc.subject.classificationMalària
dc.subject.classificationPlacebos
dc.subject.classificationAssaigs clínics
dc.subject.classificationÀfrica subsahariana
dc.subject.otherPregnant women
dc.subject.otherMalaria
dc.subject.otherPlacebos (Medicine)
dc.subject.otherClinical trials
dc.subject.otherSub-Saharan Africa
dc.titleA randomized placebo-controlled trial of intermittent preventive treatment in pregnant women in the context of insecticide treated nets delivered through the antenatal clinic
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
573164.pdf
Mida:
202.47 KB
Format:
Adobe Portable Document Format